Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Parallel, Multi-center, Phase 3 Trial to Evaluate Safety and Efficacy of PBK_M2101
Conditions
Interventions
PBK_M2101 2-Day
PBK_M2101 1-Day
+1 more
Locations
1
South Korea
Seoul Asan Medical Center
Seoul, South Korea
Start Date
June 1, 2023
Primary Completion Date
May 1, 2024
Completion Date
June 1, 2024
Last Updated
June 28, 2023
NCT06290258
NCT05199532
NCT07424469
NCT06112353
NCT06834984
NCT05041374
Lead Sponsor
Pharmbio Korea Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions